Get the Stockscreener App
453.15
1.31%
5.86
After Hours:
453.15
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Chemed Corp stock is traded at $453.15, with a volume of 174.50K.
It is up +1.31% in the last 24 hours and up +3.14% over the past month.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
See More
Previous Close:
$447.29
Open:
$449.52
24h Volume:
174.50K
Relative Volume:
0.72
Market Cap:
$6.02B
Revenue:
$2.54B
Net Income/Loss:
$259.78M
P/E Ratio:
24.70
EPS:
18.3497
Net Cash Flow:
$377.12M
1W Performance:
+3.87%
1M Performance:
+3.14%
6M Performance:
+4.11%
1Y Performance:
-17.98%
1-Day Range:
$449.52
$457.71
1-Week Range:
$428.12
$457.71
52-Week Range:
$365.20
$562.76
Chemed Corp Stock (CHE) Company Profile
Name
Chemed Corp
Sector
Industry
Phone
(513)762-6690
Address
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
453.15 | 5.94B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
386.94 | 86.02B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.94 | 15.76B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
213.36 | 13.67B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.25 | 12.81B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
99.72 | 10.14B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Sep-02-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-25-25 | Initiated | Jefferies | Hold |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Buy |
| Oct-12-18 | Initiated | BofA/Merrill | Buy |
| Aug-28-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jul-27-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-02-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-26-15 | Reiterated | Oppenheimer | Outperform |
| Oct-26-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-22-15 | Reiterated | Oppenheimer | Outperform |
| Jul-27-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-19-15 | Reiterated | Oppenheimer | Outperform |
| Sep-23-14 | Reiterated | Oppenheimer | Outperform |
| Jun-10-14 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-01-14 | Reiterated | Oppenheimer | Outperform |
| Sep-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-04-11 | Reiterated | Barclays Capital | Underweight |
| Feb-17-11 | Reiterated | Oppenheimer | Outperform |
| Feb-17-11 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Chemed Corp Stock (CHE) Latest News
Enterprise value to EBIT forward of Chemed Corp – NYSE:CHE - TradingView
Price to sales forward of Chemed Corp – NYSE:CHE - TradingView
Price to earnings forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to revenue forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to EBITDA forward of Chemed Corp – NYSE:CHE - TradingView
Behavioral Patterns of CHE and Institutional Flows - Stock Traders Daily
VITAS Healthcare Hospice Services from Chemed Corpquiet support for complex end-of-life care in t - Ad-hoc-news.de
Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Chemed Corp (CHE) Institutional Confidence - TradingKey
Chemed StockLong-term hospice and plumbing model under review - Ad-hoc-news.de
Is Chemed (NYSE:CHE) Ready For A Valuation Rebound? - Kalkine Media
Quietly essential in a crisis, Roto-Rooter Water Restoration goes beyond clogged drains - Ad-hoc-news.de
Chemed Corp (CHE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Chemed Corp (CHE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Chemed Corp (CHE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Chemed Corp (CHE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Chemed Corp (CHE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Chemed Corp (CHE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Chemed Corp (CHE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Chemed (CHE) Stock Valuation Check After Recent Mixed Performance And Undervaluation Debate - Yahoo Finance
Epoch Investment Partners Inc. Has $137.95 Million Stock Position in Chemed Corporation $CHE - MarketBeat
(CHE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Director Andrea Lindell Sells 1,347 Shares of Chemed Corp (CHE) - GuruFocus
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. By Investing.com - Investing.com South Africa
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. - Investing.com
Director Lindell sells 1,347 Chemed (NYSE: CHE) shares at $447.33 - Stock Titan
Roto-Rooter Services Company Acquires South Texas Franchise for $12 Million - Quiver Quantitative
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas - GlobeNewswire
Chemed Corp (CHE) Stock Analysis: A Robust Healthcare Play With Solid Financial Metrics - DirectorsTalk Interviews
ETFs Investing in Chemed Corporation Stocks - TradingView
VITAS CEO: CMS’ National Moratorium Disappointing - Hospice News
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
Activist Barington targets healthcare firm Chemed - MSN
Chemed Corp (CHE) Moves Higher as Stock Tests Technical Resistance LevelsComposite Profile - newsline.com
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
Chemed edges higher on report activist Barington has taken a stake - Seeking Alpha
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Australia
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Chemed (NYSE: CHE) director sells 500 shares in open-market trade - Stock Titan
CHE Q1 2026 Earnings: EPS Beats Estimates by 5.5%Pre-Earnings Drift - thelegaladvocate.com
Chemed Corp (CHE) Edges Higher Amid Steady Trading: Key Levels to WatchMA Crossover - The Legal Advocate
Chemed Corp (CHE) Q1 2026 Earnings: EPS Beats Expectations Amid Strong Operational PerformanceRevenue Surprise History - The Legal Advocate
Chemed Corp (CHE) Holds Steady Near Support Amid Narrow Trading RangeSupply Zone - The Legal Advocate
Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside - DirectorsTalk Interviews
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corp Stock (CHE) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.71%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):